Extended Lymphadenectomy Does Not Improve DFS or OS Among Patients with Localised Muscle Invasive Bladder Cancer By Ogkologos - November 4, 2024 1807 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SWOG S1011 study Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR Cancer in My Community: Overcoming Inequities in Care in Argentina January 3, 2023 Discover and translate – a mantra to work by October 17, 2022 Study Confirms Dinutuximab Extends Life for Children with High-Risk Neuroblastoma September 6, 2022 Elliot Colburn MP: Why Cancer Research UK’s Manifesto for Cancer Research... May 9, 2023 Load more HOT NEWS Empowering People With Cancer: A Q&A With Cancer.Net Editor in Chief... Science Surgery: ‘Can cancers develop in the heart?’ New on NCI Websites for July 2019 Antitumour Activity of Combination of Lenvatinib and Pembrolizumab in Patients with...
